Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer

Objectives The change in tumor fluorodeoxyglucose (FDG) uptake by positron emission tomography (PET) scan after one cycle of platinum-based chemotherapy has been shown to predict progression-free and overall survival (PFS and OS) among advanced non-small cell lung cancer (NSCLC) patients. Using earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Eaton, Keith D, Romine, Perrin E, Martins, Renato G, Leblond, Antoine, Carr, Laurie L, Vesselle, Hubert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Radiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590825/
https://www.ncbi.nlm.nih.gov/pubmed/34796077
http://dx.doi.org/10.7759/cureus.18804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590825/
https://www.ncbi.nlm.nih.gov/pubmed/34796077
http://dx.doi.org/10.7759/cureus.18804

Ejemplares similares